Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers

Molecular Psychiatry

Volumn 4, Issue 3, 1999, Pages 290-296

  Jonsson E G ^a   Nothen M M ^b   Grunhage F ^b   Farde, L ^a   Nakashima, Y ^a   Propping, P ^b   Sedvall, G C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Association; DRD2; PET; Polymorphisms; Receptor binding; 11C raclopride

Indexed keywords

BRAIN RECEPTOR; CARBON 11; DOPAMINE 2 RECEPTOR; RACLOPRIDE;

ARTICLE; CORPUS STRIATUM; DEVICE; DNA POLYMORPHISM; FEMALE; HUMAN; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR DENSITY; RECEPTOR GENE; VOLUNTEER;

EID: 0033009871     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000532     Document Type: Article

References (45)

1. 11C] raclopride in man. Synopse 1995; 20: 200-208.
2. 2 Noble EP. Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 dopamine receptor gene: with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991; 48: 648-654.
3. 3 Pohjalainen T, Rinne JO, Någren K, Lehikoinen P, Anttila K, Syvälahti EKG et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998; 3: 256-260.
4. 4 Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997; 7: 479-484.
5. 5 Farde L, Gustavsson JP. Jönsson E. D2 dopamine receptors and personality traits. Nature 1997; 385: 590.
6. 6 Farde L, Nordström A-L, Wiesel F-A, Pauli S, Halldin C, Sedvall G, Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch Gen Psychiatry 1992; 49: 538-544.
7. +1C] raclopride. J Cereb Blood Flow Metab 1993; 13: 310-314.
8. 11C-raclopride and 18F-N-methylspiroperidol. Psychiatry Res 1996; 67: 11-16.
9. 9 Wong DF, Young D, Wilson PD, Meltzer CC, Gjedde A. Quantification of neuroreceptors in the living human brain: III. D2-like dopamine receptors: theory, validation, and changes during normal aging. J Cereb Blood Flow Metab 1997; 17: 316-330.
10. 10 Wong DF, Broussolle EP, Wand G, Villemagne V, Dannals RF, Links JM et al. In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences. Ann N Y Acad Sci 1088; 515: 203-214.
11. 11 Hietala J, West C, Syvälahti E, Någren K, Lehikoinen P, Sonninen P et al. Striatal D2 dopamine receptor binding charachteristics in vivo in patients with alcohol dependence. Psychopharmacology 1994; 116: 285-290.
12. 12 Volkow ND, Wang G-J, Fowler JS, Logan J, Hitzemann R, Ding Y-S et al. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996; 20: 1594-1598.
13. 13 Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hilzemann R et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997; 386: 830-833.
14. 14 Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993; 14: 169-177.
15. 15 Wang GJ, Volkow ND, Fowler JS, Logan J, Abumrad NN, Hitzemann KJ et al. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 1997; 16: 174-182.
16. 16 Erwin VG, Womer DE, Campbell AD, Jones BC. Pharmaacokinetics of cocaine: II. Mesocorticolimbic and striatal dopamine and cocaine receptors in C57BL and DBA mice. Pharmacogenetics 1993; 3: 189-190.
17. 17 Belmaker RH, Bannet J, Brecher-Friede E, Yanai J, Ebstein RP. The effect of haloperidol feeding on dopamine receptor number in ten mouse strains. Clin Genet 1981; 19: 353-356.
18. 18 Ciaranello RE, Boehme R. Genetic regulation of neurotransmitters enzyme and receptors: relationship to the inheritance of psychiatric disorders. Behav Genet 1982; 12; 11-35.
19. 19 Fink JS. Swerdloff A, Reis DJ, Genetic control of dopamine receptors in mouse caudate-nucleus: relationship on cataleptic response to neuroleptic drugs. Neurosci Lett 1982; 32: 301-306.
20. 20 Helmeste DM, Seeman P. Genetic differences in brain dopamine receptors and amphetamine responses: possible model for hyperkinetic children. Prog Clin Biol Res 1983; 135: 401-403.
21. 21 Michaluk J, Antkiewicz-Michaluk L, Rokosz-Pelc A, Sansone M, Oliverio A, Vetulani J. Dopamine receptors in the striatum and limbic system of various strains of mice: relation to differences in responses to apomorphine. Pharmocol Biochem Beahv 1982; 17: 1115-1118.
22. 22 Kerr LM, Unis AS, Wamsley JK. Comparison of the density and distribution of brain D-1 and D-2 dopamine receptors in Buffalo vs Fischer 344 rats. Phamiucol Biochem Behav 1988; 30: 325-330.
23. 23 Helmeste DM. Spontaneous and apomorphine-indnced locomotor changes parallel dopamine receptor differences in two rat strains. Pharmacol Biochem Behav 1983; 19: 153-155.
24. 24 Rosengarten H, Schweitzer JW. Friedhoff AJ. Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats. Life Sci 1986; 39: 29-35.
25. 25 Hilzemann RJ. The regulation of DZ dopamine receptor expression. Mol Psychiatry 1998; 3: 198-203.
26. 2 receptor gene in alcoholism. J Am Med Assoc 1990; 263: 2055-2060.
27. 27 Pohjalainen T, Cravchik A, Gejman PV, Rinne J, Någren K, Syvalahti E et al. Antagonist binding characteristics of the Ser311-Cys variant of human dopamine D2 receptor in vivo and vitro. Biochem Biophys Res Commun 1997; 232: 143-146.
28. 11C] raclopride binding to D2-dopamine receptors studied by PET - a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 1989; 9: 696-708.
29. 29 Arinami T, Gao M, Hamaguchi H, Torn M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997; 6: 577-582.
30. 30 Noble EP, Gottschalk LA, Fallon JH, Ritchie TL, Wu JC. D2 dopamine receptor polymorphism and brain regional glucose metabolism. Am J Med Genet 1997; 74: 162-166.
31. 31 Laruelle M. Gelernter J, Innis RB. D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. Mol Psychiatry 1998; 3: 261-265.
32. 11C]raclopride binding in healthy young adults and schizophrenic patients - reliability and age effects. Hum Psychopharmacol 1992; 7: 157-165.
33. 33 Volkow N, Fowler J, Wang G, Dewey S, Schlyer D, MacGregor R et al. Reproducibility of repeated maesures of carbon-11-raclopride binding in the human brain. J Nucl Med 1993; 34; 609-613.
34. 34 Gelernter J, Kranzler H, Cubells JF, Ichinose H, Nagatsu T. DRD2 allele frequencies and linkage disequilibria, including the -141C Ins/Del promoter polymorphism, in European-American, African-American, and Japanese subjects. Genomics 1998; 51: 21-26.
35. 35 Nordström A-L, Olsson H, Halldin C. A PET study of D2 receptor density at different phases of the menstrual cycle. Psychiatr Res (Neuroimag) 1998; 83: 1-6.
36. 36 Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R - Non Patient Version (SCID-NP). Biometrics Research Department, New York State Psychiatric Institute: New York, 1986.
37. 37 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn - rev. American Psychiatric Association: Washington, DC, 1987, p 567.
38. 38 Nordström A-L, Farde L, Halldin C. Time course of D2-dopamine receptor occupancy examined by PET after single oral dosas of haloperidol. Psychopharmacology 1992; 106: 433-438.
39. 39 Nyberg S, Farde L, Eriksson L, Halldin C, Eriksson B. 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacology 1993; 110: 265-272.
40. 40 Nordström A-L. PET Evaluation of Dopamine Hypotheses for Antipsychotic Drugs and Schizophrenia, Karolinska Institute: Stockholm, 1993.
41. 41 Litton JE, Holte S, Eriksson L. Evaluation of the Karolinska new positron camera system; the Scanditrunix PC2048-25B. IEEE Trans Nucl Sci 1990; 37: 743-748.
42. 42 Litton J, Bergström M, Eriksson C, Bohm C, Blomqvist G, Kesselherg M. Performance study of the PC-384 positron camera system for emission tomography of the brain. J Comput Assist Tomogr 1984; 8: 74-87.
43. 43 Geijer T, Neiman J, Rydberg U, Gyllander A, Jönsson E, Sedvall G, et al. Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci 1994; 244: 26-32.
44. 44 Castiglione CM, Deinard AS, Speed WC, Sirugo G, Rosenbaum HC, Zhang Y et al. Evolution of haplotypes at the DRD2 locus. Am J Hum Genet 1995; 57: 1445-1456.
45. 45 Grandy DK, Zhang Y, Civelli O. PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mulec Genet 1993; 2: 2197.